Roivant Sciences (ROIV) P/S ratio

P/S ratio today
3251.8×

Roivant Sciences (ROIV) trades at 3251.8× its revenue per share for fiscal 2026. At the end of fiscal 2025 (March 31, 2025) its P/S ratio was 251.9×. That is 5.9% lower than the 267.8× of fiscal 2024. Figures as of 18 Nov 2026, 02:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
3251.8×
P/S ratio, fiscal 2025
251.9×
Change on fiscal 2024
−5.9%
Highest on record
267.8×fiscal 2024
Lowest on record
59.8×fiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Roivant Sciences P/S ratio, in more detail

Today's figure is 1190.8% above the fiscal 2025 year-end.

Across the 4 fiscal year-ends on record (2022–2025), the highest was 267.8× in fiscal 2024 and the lowest 59.8× in fiscal 2022. Today's P/S ratio is above every one of the 4 fiscal year-ends on record; their median is 209.4×.

History · 4 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Roivant Sciences P/S ratio, year by year

Roivant Sciences (ROIV) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today3251.8×—$38.71—
2026——$27.70$0.01
2025251.9× 5.9% down$10.09$0.04
2024267.8× 60.5% up$10.54$0.04
2023166.8× 178.8% up$7.38$0.04
202259.8×—$4.94$0.08
2021——$9.78—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Roivant Sciences and comparable companies
CompanyP/S ratio
Labcorp Holdings LH2.1×
DexCom DXCM6.6×
Roivant Sciences ROIV3395.6×
West Pharmaceutical Services WST9.4×
Quest Diagnostics DGX2.6×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on ROIV

Roivant Sciences, figure by figure

Roivant Sciences (ROIV) overview: price, valuation and scorecardAll health care companies by market value

Roivant Sciences P/S ratio: questions and answers

What is Roivant Sciences's P/S ratio?

Roivant Sciences (ROIV) trades at 3251.8× its revenue per share for fiscal 2026. At the end of fiscal 2025 (March 31, 2025) its P/S ratio was 251.9×. That is 5.9% lower than the 267.8× of fiscal 2024.

Is Roivant Sciences's P/S ratio high or low compared with its own history?

Today's P/S ratio is above every one of the 4 fiscal year-ends on record; their median is 209.4×.

What are the highest and lowest P/S ratio figures on record for Roivant Sciences?

Across the 4 fiscal year-ends on record (2022–2025), the highest was 267.8× in fiscal 2024 and the lowest 59.8× in fiscal 2022.

How is Roivant Sciences's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Roivant Sciences (ROIV) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ROIV/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.